{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:34:38Z","timestamp":1793331278054,"version":"4.5.0"},"reference-count":22,"publisher":"American Diabetes Association","issue":"5","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01-DK-107680-03"],"award-info":[{"award-number":["5R01-DK-107680-03"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Sodium\u2013glucose cotransporter 2 (SGLT2) inhibition causes an increase in endogenous glucose production (EGP). However, the mechanisms are unclear. We studied the effect of SGLT2 inhibitors on EGP in subjects with type 2 diabetes (T2D) and without diabetes (non-DM) in kidney transplant recipients with renal denervation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Fourteen subjects who received a renal transplant (six with T2D [A1C 7.2 \u00b1 0.1%] and eight non-DM [A1C 5.6 \u00b1 0.1%) underwent measurement of EGP with [3-3H]glucose infusion following dapagliflozin (DAPA) 10 mg or placebo. Plasma glucose, insulin, C-peptide, glucagon, and titrated glucose-specific activity were measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Following placebo in T2D, fasting plasma glucose (FPG) (143 \u00b1 14 to 124 \u00b1 10 mg\/dL; P = 0.02) and fasting plasma insulin (12 \u00b1 2 to 10 \u00b1 1.1 \u03bcU\/mL; P &amp;lt; 0.05) decreased; plasma glucagon was unchanged, and EGP declined. After DAPA in T2D, FPG (143 \u00b1 15 to 112 \u00b1 9 mg\/dL; P = 0.01) and fasting plasma insulin (14 \u00b1 3 to 11 \u00b1 2 \u03bcU\/mL; P = 0.02) decreased, and plasma glucagon increased (all P &amp;lt; 0.05 vs. placebo). EGP was unchanged from baseline (2.21 \u00b1 0.19 vs. 1.96 \u00b1 0.14 mg\/kg\/min) in T2D (P &amp;lt; 0.001 vs. placebo). In non-DM following DAPA, FPG and fasting plasma insulin decreased, and plasma glucagon was unchanged. EGP was unchanged from baseline (1.85 \u00b1 0.10 to 1.78 \u00b1 0.10 mg\/kg\/min) after DAPA, whereas EGP declined significantly with placebo. When the increase in EGP production following DAPA versus placebo was plotted against the difference in urinary glucose excretion (UGE) for all patients, a strong correlation (r = 0.824; P &amp;lt; 0.001) was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Renal denervation in patients who received a kidney transplant failed to block the DAPA-mediated stimulation of EGP in both individuals with T2D and non-DM subjects. The DAPA-stimulated rise in EGP is strongly related to the increase in UGE, blunting the decline in FPG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc19-2177","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T14:15:12Z","timestamp":1583504112000},"page":"1065-1069","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":26,"title":["Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion"],"prefix":"10.2337","volume":"43","clinical-trial-number":[{"clinical-trial-number":"nct03168295","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6215-9418","authenticated-orcid":false,"given":"Carolina","family":"Solis-Herrera","sequence":"first","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6301-9161","authenticated-orcid":false,"given":"Giuseppe","family":"Daniele","sequence":"additional","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"},{"name":"Section of Diabetes and Metabolic Disease, Department of Clinical and Experimental Medicine, University of Pisa and Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Alatrach","sequence":"additional","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Agyin","sequence":"additional","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Triplitt","sequence":"additional","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Adams","sequence":"additional","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupal","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2594-1651","authenticated-orcid":false,"given":"Amalia","family":"Gastaldelli","sequence":"additional","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"},{"name":"Institute of Clinical Physiology, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Honka","sequence":"additional","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Abdul-Ghani","sequence":"additional","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Cersosimo","sequence":"additional","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5388-0270","authenticated-orcid":false,"given":"Stephano","family":"Del Prato","sequence":"additional","affiliation":[{"name":"Section of Diabetes and Metabolic Disease, Department of Clinical and Experimental Medicine, University of Pisa and Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8581-6273","authenticated-orcid":false,"given":"Ralph","family":"DeFronzo","sequence":"additional","affiliation":[{"name":"Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"key":"2022031300350680000_B1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diab.37.6.667","article-title":"Lilly lecture 1987. The triumvirate: \u03b2-cell, muscle, liver. A collusion responsible for NIDDM","volume":"37","author":"DeFronzo","year":"1988","journal-title":"Diabetes"},{"key":"2022031300350680000_B2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0026-0495(89)90129-7","article-title":"Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake","volume":"38","author":"DeFronzo","year":"1989","journal-title":"Metabolism"},{"key":"2022031300350680000_B3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/dmr.5610030204","article-title":"Regulation of hepatic glucose metabolism in humans","volume":"3","author":"DeFronzo","year":"1987","journal-title":"Diabetes Metab Rev"},{"key":"2022031300350680000_B4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1172\/JCI113572","article-title":"Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes","volume":"82","author":"Chen","year":"1988","journal-title":"J Clin Invest"},{"key":"2022031300350680000_B5","first-page":"4059","article-title":"Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus","volume":"81","author":"Cusi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300350680000_B6","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/diabetes.48.5.1198","article-title":"Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo","volume":"48","author":"Cherrington","year":"1999","journal-title":"Diabetes"},{"key":"2022031300350680000_B7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2337\/diabetes.47.4.523","article-title":"Basal hepatic glucose production is regulated by the portal vein insulin concentration","volume":"47","author":"Sindelar","year":"1998","journal-title":"Diabetes"},{"key":"2022031300350680000_B8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1172\/JCI114142","article-title":"Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance","volume":"84","author":"Groop","year":"1989","journal-title":"J Clin Invest"},{"key":"2022031300350680000_B9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1172\/JCI109404","article-title":"Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man","volume":"63","author":"Rizza","year":"1979","journal-title":"J Clin Invest"},{"key":"2022031300350680000_B10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI70704","article-title":"Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production [published corection appears in J Clin Invest 2014;124:2287]","volume":"124","author":"Merovci","year":"2014","journal-title":"J Clin Invest"},{"key":"2022031300350680000_B11","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2014-3472","article-title":"Dapagliflozin lowers plasma glucose concentration and improves \u03b2-cell function","volume":"100","author":"Merovci","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300350680000_B12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneph.2016.170","article-title":"Renal, metabolic and cardiovascular considerations of SGLT2 inhibition","volume":"13","author":"DeFronzo","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2022031300350680000_B13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients","volume":"124","author":"Ferrannini","year":"2014","journal-title":"J Clin Invest"},{"key":"2022031300350680000_B14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nm.3828","article-title":"Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion","volume":"21","author":"Bonner","year":"2015","journal-title":"Nat Med"},{"key":"2022031300350680000_B15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1152\/ajplegacy.1956.187.1.15","article-title":"Measurement of size and turnover rate of body glucose pool by the isotope dilution method","volume":"187","author":"Steele","year":"1956","journal-title":"Am J Physiol"},{"key":"2022031300350680000_B16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.transproceed.2010.03.125","article-title":"Native kidney function after renal transplantation combined with other solid organs in preemptive patients","volume":"42","author":"Mosconi","year":"2010","journal-title":"Transplant Proc"},{"key":"2022031300350680000_B17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00007890-199801150-00019","article-title":"Contribution of native kidney function to total glomerular filtration rate after combined kidney-pancreas transplantation","volume":"65","author":"Pascual","year":"1998","journal-title":"Transplantation"},{"key":"2022031300350680000_B18","first-page":"E792","article-title":"Effects of beta-adrenergic blockade on hepatic and renal glucose production during hypoglycemia in conscious dogs","volume":"275","author":"Cersosimo","year":"1998","journal-title":"Am J Physiol"},{"key":"2022031300350680000_B19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.metabol.2004.01.018","article-title":"Effects of hyperglycemia, glucagon, and epinephrine on renal glucose release in the conscious dog","volume":"53","author":"Gustavson","year":"2004","journal-title":"Metabolism"},{"key":"2022031300350680000_B20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2174\/1573399814666180813124645","article-title":"Hormonal, metabolic and hemodynamic adaptations to glycosuria in type 2 diabetes patients treated with sodium-glucose co-transporter inhibitors","volume":"15","author":"Cersosimo","year":"2019","journal-title":"Curr Diabetes Rev"},{"key":"2022031300350680000_B21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000016312","article-title":"Impact of culture conditions, culture media volumes, and glucose content on metabolic properties of renal epithelial cell cultures. Are renal cells in tissue culture hypoxic?","volume":"9","author":"Gstraunthaler","year":"1999","journal-title":"Cell Physiol Biochem"},{"key":"2022031300350680000_B22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1172\/JCI109718","article-title":"Epinephrine-induced insulin resistance in man","volume":"65","author":"Deibert","year":"1980","journal-title":"J Clin Invest"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc19-2177","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/5\/1065\/631172\/dc192177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/5\/1065\/631172\/dc192177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T22:53:35Z","timestamp":1647125615000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/5\/1065\/35715\/Increase-in-Endogenous-Glucose-Production-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,3,6]]},"published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc19-2177","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]}}}